Cargando…
Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3
Klebsiella pneumoniae is responsible for nosocomial infections causing significant morbidity and mortality. Treatment of newly emerging multi-drug resistant strains is hampered due to severely limited antibiotic choices. Passive immunization targeting LPS O-antigens has been proposed as an alternati...
Autores principales: | Guachalla, Luis M., Stojkovic, Katarina, Hartl, Katharina, Kaszowska, Marta, Kumar, Yadhu, Wahl, Benjamin, Paprotka, Tobias, Nagy, Eszter, Lukasiewicz, Jolanta, Nagy, Gábor, Szijártó, Valéria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529442/ https://www.ncbi.nlm.nih.gov/pubmed/28747785 http://dx.doi.org/10.1038/s41598-017-06682-2 |
Ejemplares similares
-
Identification of d-Galactan-III As Part of the Lipopolysaccharide of Klebsiella pneumoniae Serotype O1
por: Stojkovic, Katarina, et al.
Publicado: (2017) -
Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30
por: Guachalla, Luis M., et al.
Publicado: (2017) -
Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258
por: Szijártó, Valéria, et al.
Publicado: (2017) -
Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain
por: Guachalla, Luis M., et al.
Publicado: (2018) -
A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway
por: Mutti, Michele, et al.
Publicado: (2018)